Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 37,500 | |||
5 mg | 在庫あり | ¥ 75,500 | |||
10 mg | 在庫あり | ¥ 129,500 | |||
25 mg | 在庫あり | ¥ 204,500 | |||
50 mg | 在庫あり | ¥ 282,500 | |||
100 mg | 在庫あり | ¥ 383,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 84,000 |
説明 | NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties. |
In vitro | NRC-2694 (80 ng) induce comparable inhibition of EGFR expression. |
In vivo | NRC-2694 (10 mg/kg) regresses the tumor in mice. The maximum tolerated dose of NRC-2694 in male and female mice is 2000 mg/kg (p.o.), in toxicity studies . |
分子量 | 418.49 |
分子式 | C24H26N4O3 |
CAS No. | 936446-61-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (597.39 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NRC-2694 936446-61-6 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR inhibit HER1 Epidermal growth factor receptor ErbB-1 Inhibitor NRC2694 NRC 2694 inhibitor